Generated by GPT-5-mini| Mentor Worldwide | |
|---|---|
| Name | Mentor Worldwide |
| Type | Subsidiary |
| Industry | Medical devices |
| Founded | 1969 |
| Founder | Abraham Palatchi |
| Headquarters | Irvine, California |
| Key people | Frank J. Âucoin |
| Products | Breast implants, tissue expanders, aesthetic devices |
| Parent | Johnson & Johnson |
Mentor Worldwide
Mentor Worldwide is a medical device company specializing in breast aesthetics and reconstruction products. The company develops and markets implantable devices, tissue expanders, and related surgical instruments used by plastic surgeons, oncologic surgeons, and reconstructive specialists. Its operations intersect with major healthcare institutions, regulatory agencies, and professional societies in plastic and reconstructive surgery.
Founded in the late 20th century by entrepreneurs associated with early silicone implant development, the company expanded through product innovation and acquisitions. It grew amid regulatory attention from agencies such as U.S. Food and Drug Administration and legal scrutiny exemplified by mass tort litigation like the Breast implant litigation precedent. Corporate milestones include acquisition by multinational healthcare conglomerates and alignment with research centers at academic institutions such as Johns Hopkins Hospital and Mayo Clinic. The firm’s timeline intersects with industry peers including Allergan, Sientra, and historical manufacturers like Dow Corning.
The company offers a range of implantable breast devices, including silicone gel-filled implants and saline implants used in cosmetic augmentation and post-mastectomy reconstruction. It supplies tissue expanders used in staged reconstruction and surgical accessories such as insertion tools and anatomically contoured devices. Clinical offerings extend to training programs for surgeons affiliated with professional bodies like the American Society of Plastic Surgeons and product distribution through medical supply channels linked to hospitals such as Cleveland Clinic and health systems like Kaiser Permanente. Competing product lines often reference technologies developed by firms such as Mentor Corporation (historical brand origins), Allergan plc, and Establishment Labs.
Operated as a division within a multinational healthcare group, the company is controlled by a corporate parent that manages subsidiaries across medical devices, pharmaceuticals, and consumer health. Its governance involves boards and executive teams with backgrounds from institutions like Harvard Business School and consulting firms such as McKinsey & Company. Financial transactions and mergers have been reviewed by regulators including the Securities and Exchange Commission and subject to antitrust considerations involving competitors like Johnson & Johnson and Pfizer in broader corporate portfolios.
The company supports preclinical and clinical research programs in collaboration with academic centers including Stanford University School of Medicine and University of California, Los Angeles (UCLA). Clinical trials are registered with entities tracking human research and often adhere to protocols influenced by recommendations from societies such as the International Society of Aesthetic Plastic Surgery and the European Association of Plastic Surgeons. Educational activities include fellowship sponsorships, surgeon workshops at conferences like the American Society for Aesthetic Plastic Surgery annual meeting, and cadaver labs coordinated with medical schools such as Yale School of Medicine.
Regulatory interactions include approvals, post-market surveillance, and device labeling reviewed by authorities such as the U.S. Food and Drug Administration, the European Medicines Agency, and national regulators in countries like Canada and Australia. Safety monitoring involves reporting to national vigilance systems and participation in registries akin to those championed by the National Cancer Institute for oncologic outcomes. The company’s devices have been subject to safety evaluations paralleling scrutiny experienced by industry peers during episodes like the Poly Implant Prothèse (PIP) scandal and follow-up studies led by researchers at institutions like Harvard Medical School.
Marketing efforts target professional audiences and patient education, including exhibition at medical conferences such as The Aesthetic Meeting and sponsorship of symposia hosted by organizations like the American Society of Plastic Surgeons. Patient-facing materials liaise with advocacy groups including Susan G. Komen and breast cancer reconstruction networks at hospitals like Memorial Sloan Kettering Cancer Center. Advertising and promotional compliance are overseen in jurisdictions with codes enforced by bodies like the Federal Trade Commission and national advertising standards authorities.
Category:Medical device companies Category:Breast surgery